These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 12011284
1. MAOB intron 13 and COMT codon 158 polymorphisms, cigarette smoking, and the risk of PD. Hernán MA, Checkoway H, O'Brien R, Costa-Mallen P, De Vivo I, Colditz GA, Hunter DJ, Kelsey KT, Ascherio A. Neurology; 2002 May 14; 58(9):1381-7. PubMed ID: 12011284 [Abstract] [Full Text] [Related]
2. A meta-analysis on relationship of MAOB intron 13 polymorphisms, interactions with smoking/COMT H158L polymorphisms with the risk of PD. Zhang Y, Piao X, Wu J, Li Y, Liang Q. Int J Neurosci; 2016 May 14; 126(5):400-7. PubMed ID: 26000819 [Abstract] [Full Text] [Related]
3. The COMT L allele modifies the association between MAOB polymorphism and PD in Taiwanese. Wu RM, Cheng CW, Chen KH, Lu SL, Shan DE, Ho YF, Chern HD. Neurology; 2001 Feb 13; 56(3):375-82. PubMed ID: 11171904 [Abstract] [Full Text] [Related]
4. The effect of monoamine oxidase B (MAOB) and catechol-O-methyltransferase (COMT) polymorphisms on levodopa therapy in patients with sporadic Parkinson's disease. Białecka M, Droździk M, Kłodowska-Duda G, Honczarenko K, Gawrońska-Szklarz B, Opala G, Stankiewicz J. Acta Neurol Scand; 2004 Oct 13; 110(4):260-6. PubMed ID: 15355491 [Abstract] [Full Text] [Related]
5. Genetic polymorphisms involved in dopaminergic neurotransmission and risk for Parkinson's disease in a Japanese population. Kiyohara C, Miyake Y, Koyanagi M, Fujimoto T, Shirasawa S, Tanaka K, Fukushima W, Sasaki S, Tsuboi Y, Yamada T, Oeda T, Shimada H, Kawamura N, Sakae N, Fukuyama H, Hirota Y, Nagai M, Fukuoka Kinki Parkinson's Disease Study Group. BMC Neurol; 2011 Jul 25; 11():89. PubMed ID: 21781348 [Abstract] [Full Text] [Related]
6. Association of monoamine oxidase B and catechol-O-methyltransferase polymorphisms with sporadic Parkinson's disease in an Iranian population. Torkaman-Boutorabi A, Ali Shahidi G, Choopani S, Reza Zarrindast M. Folia Neuropathol; 2012 Jul 25; 50(4):382-9. PubMed ID: 23319194 [Abstract] [Full Text] [Related]
7. Catechol-O-methyltransferase and monoamine oxidase B genes and susceptibility to sporadic Parkinson's disease in a Polish population. Białecka M, Droździk M, Honczarenko K, Gawrońska-Szklarz B, Stankiewicz J, Dabrowska E, Kubisiak M, Kłodowska-Duda G, Opala G. Eur Neurol; 2005 Jul 25; 53(2):68-73. PubMed ID: 15753616 [Abstract] [Full Text] [Related]
8. The catechol-O-methyltransferase and monoamine oxidase B polymorphisms and levodopa therapy in the Iranian patients with sporadic Parkinson's disease. Torkaman-Boutorabi A, Shahidi GA, Choopani S, Rezvani M, Pourkosary K, Golkar M, Zarrindast MR. Acta Neurobiol Exp (Wars); 2012 Jul 25; 72(3):272-82. PubMed ID: 23093014 [Abstract] [Full Text] [Related]
9. Impact of COMT H108L, MAOB int 13 A>G and DRD2 haplotype on the susceptibility to Parkinson's disease in South Indian subjects. Kumudini N, Umai A, Devi YP, Naushad SM, Mridula R, Borgohain R, Kutala VK. Indian J Biochem Biophys; 2013 Oct 25; 50(5):436-41. PubMed ID: 24772965 [Abstract] [Full Text] [Related]
10. Association study of monoamine oxidase and catechol-O-methyltransferase genes with smoking behavior. Tochigi M, Suzuki K, Kato C, Otowa T, Hibino H, Umekage T, Kato N, Sasaki T. Pharmacogenet Genomics; 2007 Oct 25; 17(10):867-72. PubMed ID: 17885625 [Abstract] [Full Text] [Related]
11. Functional monoamine oxidase B gene intron 13 polymorphism predicts putaminal dopamine turnover in de novo Parkinson's disease. Löhle M, Mangone G, Wolz M, Beuthien-Baumann B, Oehme L, van den Hoff J, Kotzerke J, Reichmann H, Corvol JC, Storch A. Mov Disord; 2018 Sep 25; 33(9):1496-1501. PubMed ID: 30216543 [Abstract] [Full Text] [Related]
12. Modification of the association between early adversity and obsessive-compulsive disorder by polymorphisms in the MAOA, MAOB and COMT genes. McGregor NW, Hemmings SMJ, Erdman L, Calmarza-Font I, Stein DJ, Lochner C. Psychiatry Res; 2016 Dec 30; 246():527-532. PubMed ID: 27821364 [Abstract] [Full Text] [Related]
13. Variations in the monoamine oxidase B (MAOB) gene are associated with Parkinson's disease. Mellick GD, Buchanan DD, McCann SJ, James KM, Johnson AG, Davis DR, Liyou N, Chan D, Le Couteur DG. Mov Disord; 1999 Mar 30; 14(2):219-24. PubMed ID: 10091612 [Abstract] [Full Text] [Related]
14. Relationships of Cerebrospinal Fluid Alzheimer's Disease Biomarkers and COMT, DBH, and MAOB Single Nucleotide Polymorphisms. Babić Leko M, Nikolac Perković M, Klepac N, Švob Štrac D, Borovečki F, Pivac N, Hof PR, Šimić G. J Alzheimers Dis; 2020 Mar 30; 73(1):135-145. PubMed ID: 31771069 [Abstract] [Full Text] [Related]
15. The relationship between monoamine oxidase B (MAOB) A644G polymorphism and Parkinson disease risk: a meta-analysis. Liu Y, Wang Z, Zhang B. Ann Saudi Med; 2014 Mar 30; 34(1):12-7. PubMed ID: 24658549 [Abstract] [Full Text] [Related]
16. Association of Catechol-O-Methyltransferase and monoamine oxidase B gene polymorphisms with motor complications in parkinson's disease in a Chinese population. Hao H, Shao M, An J, Chen C, Feng X, Xie S, Gu Z, Chan P, Chinese Parkinson Study Group. Parkinsonism Relat Disord; 2014 Oct 30; 20(10):1041-5. PubMed ID: 25034874 [Abstract] [Full Text] [Related]
18. MAO-B and COMT Genetic Variations Associated With Levodopa Treatment Response in Patients With Parkinson's Disease. Sampaio TF, Dos Santos EUD, de Lima GDC, Dos Anjos RSG, da Silva RC, Asano AGC, Asano NMJ, Crovella S, de Souza PRE. J Clin Pharmacol; 2018 Jul 30; 58(7):920-926. PubMed ID: 29578580 [Abstract] [Full Text] [Related]
19. [Polymorphisms of catechol-O-methyltransferase and monoamine oxidase B genes among Chinese patients with Parkinson's disease]. Hao H, Shao M, An J, Chen C, Feng X, Xie S, Gu Z, Chen B. Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Feb 30; 32(1):1-5. PubMed ID: 25636089 [Abstract] [Full Text] [Related]